STAT

MARCH 3, 2023

That technology, which enables scientists to easily excise, alter, or replace specific sections of DNA, was awarded the 2020 Nobel Prize for Chemistry.

99

99

Outsourcing Pharma

OCTOBER 7, 2020

The latest news on pharmaceutical industry hires, promotions, acquititions and other events includes Medable, Eversana, Parexel, Astellas and more.

98

98

DiversifyRx

OCTOBER 12, 2022

This event is a great time to leverage local media and doctors to grow your pharmacy while keeping your community safe. Officially, this is a DEA-sanctioned event where pharmacies are allowed to take back controlled drugs. I never had a doctor’s office refuse to promote a drug take-back event.

Independent Pharmacies 97

Independent Pharmacies 97

Pharmaceutical Technology

FEBRUARY 2, 2023

Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.

FDA 98

FDA 98

Pharma Times

SEPTEMBER 29, 2023

FlyPharma Europe is an event for the pharma logistics industry, connecting professionals from across the globe - News - PharmaTimes

48

48

Digital Pharmacist

FEBRUARY 29, 2024

Originally announced with public service announcements, news releases, and bumper stickers which promoted special nutrition events hosted in schools, health care facilities, and community centers, the campaign caught national attention with districts and state associations being prompted to host their own events.

Health and Personal Care Stores 111

Health and Personal Care Stores 111

STAT

JANUARY 4, 2024

… Starting April 1, CVS Health will no longer offer AbbVie’s Humira to patients in its commercial prescription plans and, instead, will direct them to biosimilar versions of the anti-inflammatory drug that became available last year , Bloomberg News writes.

FDA 118

FDA 118

Hospital Pharmacy Europe

OCTOBER 20, 2023

NHS England’s Cancer Drug’s Fund Lead, Professor Peter Clark, said: ’The approval of this drug is great news for people living with an advanced and aggressive form of blood cancer, who are set to benefit from this new treatment. The most common adverse event was cytokine release syndrome (CRS) (63%).

Chemotherapy 52

Chemotherapy Immunization Hospitals 52

Outsourcing Pharma

OCTOBER 7, 2021

This monthâs news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

52

52

PharmaShots

MAY 30, 2023

The results from the inhibitor cohort of the (BASIS) trial are expected in 2024 Ref: BusinessWire | Image: Pfizer Related News:- Pfizer Reports the US FDA’s Acceptance of sNDA for Braftovi + Mektovi to Treat Metastatic Non-Small Cell Lung Cancer PharmaShots! Your go-to media platform for customized news ranging for multiple indications.

FDA 40

FDA 40

Pharma Times

JUNE 21, 2023

During research there were not any clinically-relevant adverse events or psychotomimetic effects - News - PharmaTimes

42

42

PQA

MARCH 8, 2024

We are in the early stages of planning an event, PQA Convenes: Quality Medication Use in Rare Disease, which will bring our members and the rare disease community together to explore quality in medication use. If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email! Learn more below.

Community Pharmacies 52

Community Pharmacies Specialty Pharmacies Independent Pharmacies Documentation 52

The Honest Apothecary

MAY 4, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. READ YESTERDAY’S NEWS. NEWS FLASH! The initial news stories made it sound like AI simply did better than physicians. HEALTHCARE IT NEWS. by the year 2030.

84

84

Outsourcing Pharma

DECEMBER 2, 2020

This monthâs news about industry hires, promotions, acquisitions and other events includes Signant, PRA, Lonza, Bora Pharmaceuticals and other top firms.

52

52

PQA

OCTOBER 20, 2023

This year's summit will advance measure modernization, while the convening event will address the state of MTM practice and opportunities to evolve MTM measurement.Leadership Summit attendees are invited to participate in both events. These events is an invitation-only event for PQA member organization leaders.

Specialty Pharmacies 52

Specialty Pharmacies Medical Records Medication Delivery Patient Care 52

PharmaShots

JUNE 16, 2023

The company intends to work with the US FDA to lift the partial clinical hold and restart enrollment in (UP-NEXT) and (UPGRADE-A) trial Ref: Globenewswire | Image: Mersana Related News:- Merck Signs a Research Collaboration and Commercial License Agreement with Mersana for Novel Antibody-Drug Conjugates PharmaShots!

FDA 40

FDA 40

PharmaShots

APRIL 10, 2023

The decision was based on previously disclosed cardiac events that occurred in two participants who received MT-0169 at a 50mcg/kg dose One patient experienced asymptomatic grade 2 myocarditis, while the other had asymptomatic grade 3 cardiomyopathy & the dosage of MT-0169 was reduced by 90% to 5mcg/kg last year.

FDA 40

FDA Dosage 40

PharmaShots

MAY 23, 2023

Vadadustat also achieved the primary safety EPs & showed non-inferiority of vadadustat in time to the first occurrence of major adverse cardiovascular events Ref: PR Newswire | Image: Akebia Related News:- Akebia Receives EC’s Marketing Authorisation of Vafseo (vadadustat) for the Treatment of Symptomatic Anaemia PharmaShots!

40

40

PharmaShots

MARCH 24, 2023

The safety profile was consistent with the prior studies across other indications with no new safety risks Serious AEs (2.3% vs 10.2%); rates of serious inf.

40

40

PharmaShots

JUNE 26, 2023

ABR & maintenance of factor VIII activity above pre-specified levels No serious allergic reactions, anaphylaxis, or embolic or thrombotic events were seen. Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

40

40

PharmaShots

MAY 12, 2023

If bentracimab is approved by the US FDA, it allows patients to benefit from the antithrombotic effect of ticagrelor, preventing vascular events & reducing the risk of death Ref: Globenewswire | Image: SERB Related News:- PhaseBio Signs a Supply Agreement with BioVectra to Support the Development and Commercialization of Bentracimab

FDA 53

FDA 53

PharmaShots

APRIL 5, 2023

Shots: The P-IIb dose-finding study evaluates vidofludimus calcium vs PBO in patients at 78 study sites in the US and EU The 50wk. maintenance phase results showed a dose-linear increase in clinical remission, 10 & 30mg, qd of vidofludimus calcium showed clinical remission rate (42.3% & 61.5%

Immunization 40

Immunization 40

PharmaShots

JUNE 21, 2023

who have a history of vaso-occlusive events (VOEs). Your go-to media platform for customized news ranging for multiple indications. Shots: The US FDA has accepted the BLA for priority review of lovotibeglogene autotemcel for individuals with SCD aged ≥12yrs. follow-up and 2 patients in the (HGB-210) study with 18mos. of follow-up.

FDA 40

FDA 40

PharmaShots

JUNE 14, 2023

Shots: The company has completed the first dose cohort & dosing of 1st patient in the second dose cohort in the P-I/II trial (SUNRISE-FA) evaluating LX2006 (IV) in patients with FA cardiomyopathy LX2006 was found to be well tolerated with no unexpected events or toxicities in 1st dose cohort. post-LX2006 treatment.

FDA 40

FDA 40

PharmaShots

MARCH 21, 2023

The safety profile was consistent with prior studies, grade ≥3 CRS & neurologic events were seen in 7% & 25% while 83% had high-grade events in the SOC arm Ref: Businesswire | Image: Kite Related News:- Kite’s Yescarta Receives EC’s Approval as 2L Treatment of Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

40

40

PharmaShots

JUNE 8, 2023

along with time from randomization to the first occurrence of composite kidney failure endpoint event. Ref: Globe Newswire | Image: Vera Related News:- Vera Seeks to Initiate P-III Clinical Trial of Atacicept for the Treatment of Lupus Nephritis PharmaShots! followed by a 52wk. and change in Gd-IgA1 & eGFR up to 52wk.

Labelling 40

Labelling 40

Pharma Marketing Network

FEBRUARY 16, 2021

You have a list of all of the presentations you plan on attending during the three-day pharmaceutical conference in New Orleans, and all of your lines have been practiced in front of a mirror for when you go to interview some of the keynote speakers. The second step is to choose the right time and day to host your virtual event.

Communication 98

Communication 98

PharmaShots

MAY 22, 2023

The therapy was well tolerated with no drug-related SAEs or discontinuations due to treatment-related events In the (GEM-1/2) trial, the results showed durable wound closure, expression of full-length COL7 in the skin, and anchoring fibril assembly with minimal reported AEs. For more information connect with us at connect@pharmashots.com

40

40

PharmaShots

MAY 17, 2023

Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

FDA 40

FDA 40

PQA

MAY 3, 2024

PQA SAMs are members-only events that are held quarterly to share current and relevant measure development and maintenance updates. This webinar precedes the April 8 - 26 member voting period. The registration link is in the Member Resources Library. PQA's 2nd Quarter 2024 Stakeholder Advisory Meeting is June 5, 1:00-1:30 pm ET.

Specialty Pharmacies 52

Specialty Pharmacies 52

PQA

AUGUST 25, 2023

This PQA Convenes event is part of a national initiative to advance medication therapy management (MTM) quality measurement and other strategies to evaluate MTM services. Learn more about these events below.We If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email!

Patient Care 52

Patient Care Immunization 52

Viseven

OCTOBER 3, 2023

Veeva APAC Commerical Summit is one of the most prominent events in the Asia-Pacific region where leading companies in biopharma connect, share professional expertise, network, and have fun. This year’s APAC Commercial Summit was no exception.

52

52

PQA

FEBRUARY 9, 2024

Registration is open, so make your plans now to join us and other quality professionals at the premier event for medication use quality. PQA SAMs are members-only events that are held quarterly to share current and relevant measure development and maintenance updates. Review these opportunities in the Sponsorship Prospectus.

59

59

The FDA Law Blog

DECEMBER 21, 2023

In other exciting news — in 2024 FDLI will be getting a make-over! Those who attended their annual Enforcement, Litigation, and Compliance Conference holiday reception earlier this month got a sneak peek at this new branding effort with the unveiling of the association’s new logo ( here ).

FDA 59

FDA 59

PharmaShots

MAY 4, 2023

with no CRs) Low-grade ocular & gastrointestinal events continue to dominate the safety profile of Elahere. No new safety signals were seen, lower rates of grade ≥3 TEAEs (42% vs 54%); SAEs (24% vs 33%); study drug discontinuation due to TEAEs (9% vs 16%). vs 12.75mos.), vs 3.98mos.), 12 CRs vs 15.9%

FDA 40

FDA 40

Outsourcing Pharma

NOVEMBER 5, 2020

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

40

40

STAT

JULY 10, 2023

Weight loss medications from Novo Nordisk are being investigated by the European Medicines Agency after several reports of suicidal risks were referred to the watchdog , Bloomberg News reports. One additional case relating to thoughts of self-injury has been raised in connection with Saxenda.

96

96